Continuous-Flow Synthesis of the Anti-Malaria Drug Artemisinin
- François Lévesque1
- Peter H. Seeberger1,2
- 1Department for Biomolecular Systems, Max-Planck Institute for Colloids and Interfaces, Germany
- 2Institute for Chemistry and Biochemistry, Freie Universität Berlin, GermanyRead the publication that featured this abstract
Malaria is a serious global health issue. Artemisinin combination treatments are the first-line drugs, but supplies are limited because artemisinin is obtained solely by extraction from Artemisia annua. A continuous-flow process that converts dihydroartemisinic acid into artemisinin (see scheme) was shown to be an inexpensive and scalable process that can ensure a steady, affordable supply of artemisinin.
The Vapourtec R-Series is, quite simply, unrivalled for flow chemistry
- Flexible |
- Precise |
The R-Series is undoubtedly the most versatile, modular flow chemistry system available today.
The Vapourtec E-Series is the perfect introductory system for flow chemistry
- Robust |
- Easy to use |
The E-Series is a robust and affordable, entry level flow chemistry system designed for reliability and ease of use.